This compound is a peptide synthesis intermediate featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a modified amino acid backbone with a dimedone-derived side chain. It is primarily used in the laboratory-scale or manufacturing preparation of specialized peptides.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 235788-61-1
Fmoc-D-Lys(Dde)-OH
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-L-lysine
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-2,4-diaminobutyric acid
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine
pharmaceutical intermediate
Fmoc-AEEA-AEEA
pharmaceutical intermediate
N(alpha)-t-butoxycarbonyl-L-asparagine
pharmaceutical intermediate
(S)-2-((S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID
pharmaceutical intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]butanoic acid
AFBHGOUICAXOQZ-QHCPKHFHSA-N
CC(=NCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C4=C(CC(CC4=O)(C)C)O